Redhill Biopharma Ltd. - ADR
RDHL
Market Cap$8.18K
Close$
$-1.91
203.3% downside
Current Fair Value
203.3% downsideOvervalued by 203.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8,181.00 |
|---|---|
| Enterprise Value | $-4,252,819.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-512 |
| Beta | 4.33 |
| Outstanding Shares | 7,987 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | -0.12 |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | -0.08 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Redhill Biopharma
CEO: Dror Ben-Asher